France Pharmacovigilance Market Size & Outlook, 2023-2030
France pharmacovigilance market, 2018-2030 (US$M)
Related Markets
France pharmacovigilance market highlights
- The France pharmacovigilance market generated a revenue of USD 268.0 million in 2023 and is expected to reach USD 445.6 million by 2030.
- The France market is expected to grow at a CAGR of 7.5% from 2024 to 2030.
- In terms of segment, phase 4 was the largest revenue generating product life cycle in 2023.
- Phase 3 is the most lucrative product life cycle segment registering the fastest growth during the forecast period.
Pharmacovigilance market data book summary
| Market revenue in 2023 | USD 268.0 million |
| Market revenue in 2030 | USD 445.6 million |
| Growth rate | 7.5% (CAGR from 2023 to 2030) |
| Largest segment | Phase 4 |
| Fastest growing segment | Phase 3 |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pre Clinical, Phase 1, Phase 2, Phase 3, Phase 4 |
| Key market players worldwide | Accenture PLC Class A, IQVIA Holdings Inc, Cognizant Technology Solutions Corp Class A, Linical Americas, International Business Machines Corp, Labcorp Holdings Inc, ArisGlobal, Capgemini SE, ITClinical, Icon PLC, TAKE Solutions, PAREXEL, Wipro Ltd ADR, United Biosource Corporation, FMD K&L, BioClinica |
Other key industry trends
- In terms of revenue, France accounted for 3.7% of the global pharmacovigilance market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany pharmacovigilance market is projected to lead the regional market in terms of revenue in 2030.
- Spain is the fastest growing regional market in Europe and is projected to reach USD 232.0 million by 2030.
Phase 4 was the largest segment with a revenue share of 75.86% in 2023. Horizon Databook has segmented the France pharmacovigilance market based on pre clinical, phase 1, phase 2, phase 3, phase 4 covering the revenue growth of each sub-segment from 2018 to 2030.
The pharmacovigilance market in France is expected to grow at a lucrative rate in the coming years owing to the increasing ADR reporting in the country. For instance, according to a study conducted by EMIR, 143,915 patients were hospitalized due to ADR.
Moreover, France is an important hub for clinical research activities in Europe, and various clinical studies are being conducted in this country. In addition, countries such as France & Germany are engaged in information exchange related to their national research & innovation strategies.
This is likely to help these countries take joint action and plays an important role in ensuring the best clinical research activities. Such initiatives are expected to propel the market growth over the forecast period.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmacovigilance Market Scope
Pharmacovigilance Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France pharmacovigilance market size, by product life cycle, 2018-2030 (US$M)
France Pharmacovigilance Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
